“Micro Interventional Devices Inc. (MID) recently announced the second successful implantation of its MIA (Minimally Invasive Annuloplasty) technology.”
Visit Website“Entering their pre-market phase of development, Materialise is working with select U.S. and EU hospital partners to validate the importance of accurate 3-D modeling to help physicians plan complex transcatheter mitral valve replacement and repair (TMVR/r) procedures.”
Visit Website“CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra PzF NanoCoated Coronary Stent (NCS) with 14-day dual antiplatelet therapy (DAPT) in complex patients, such as those who are at high bleeding risk.”
Visit Website“Adam Greenbaum, M.D., co-director of the structural heart program at Henry Ford Health System in Detroit, discusses the innovative approach to transcatheter aortic valve replacement (TAVR) being pioneered at HFHS.”
Visit Website“Here is an aggregation of DAIC news, videos and articles for recent heart valve technology advances in 2017.”
Visit Website“CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic heart device to support heart function.”
Visit Website“Here is an aggregation of DAIC content for all major cardiovascular technology news and advances this past year.”
Visit Website“Medical professionals representing hospital systems from across the United States are expected to attend the first National Cardiogenic Shock Initiative (NCSI) meeting Oct. 29 in Denver. The gathering will help kick off Transcatheter Cardiovascular Therapeutics (TCT) 2017, an annual educational meeting specializing in interventional cardiovascular medicine.”
Visit Website“The National Institutes of Health has awarded Detroit cardiologist Adam Greenbaum, M.D., for his pioneering work on the novel transcaval heart procedure.”
Visit Website“Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-computed tomography) Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath GRX System to evaluate the feasibility and utility of clinical decision support.”
Visit Website